低骨量要不要干预治疗？讨论(二)  

Is it essential to decide about the management of osteopenia?

作　　者：季颖[1] 阮祥燕[1] 刘忠厚 

机构地区：[1]首都医科大学附属北京妇产医院内分泌诊疗中心,北京100026 [2]中国老年学学会骨质疏松委员会,100102

出　　处：《中国骨质疏松杂志》2008年第7期521-524,共4页Chinese Journal of Osteoporosis

摘　　要：临床研究证实骨量减少不能完全预测骨折的风险,各个国家地区以及骨质疏松相关学科的专业学术团体也有着不同干预阈值标准。笔者回顾了国内外多篇骨质疏松诊疗指南和诊治原则,对比并总结了骨密度测定的临床指征、骨质疏松以及骨质疏松性骨折危险因子和不同的干预阈值标准。建议在选择采取骨质疏松及骨质疏松性骨折防治措施时,综合评估骨密度和骨质疏松及其骨折危险因素,共同预测骨质疏松症及其骨折的发生情况,从而在较为恰当的时机进行骨质疏松的干预措施与治疗并开展有效的随访。Clinical researches confirm that osteopenia is only one of factors that predict the risk of fracture. There are different standards of intervention threshold among different countries and areas. This article reviews many guidelines and summarizes the clinical indications for bone density testing, the intervention thresholds of osteoporosis and osteoporotic fracture. It is suggested that evaluation of BMD associated with the risk of osteoporosis and osteoporotic fracture be helpful to predict the occurrence of osteoporosis and osteoporotic fracture.

关 键 词：骨量减少 危险因素 干预阈值 

分 类 号：R336[医药卫生—人体生理学]